Finance

Beta
Lists
GLMD:NASDAQ
Galmed Pharmaceuticals Ltd
$0.54
-4.88%
(-0.028) 1D
Jul 10, 12:40:48 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GLMD...
Open
$0.56
High
$0.57
Low
$0.54
Mkt. cap
4.17M
Avg. vol.
899.95K
Volume
17.54K
52-wk high
$2.34
52-wk low
$0.41
EPS
-$2.07
Beta
0.74
Shares outstanding
7.68M
No. of employees
5
Open
$0.56
High
$0.57
Low
$0.54
Mkt. cap
4.17M
Avg. vol.
899.95K
Volume
17.54K
52-wk high
$2.34
52-wk low
$0.41
EPS
-$2.07
Beta
0.74
Shares outstanding
7.68M
No. of employees
5
News stories
From sources across the web
About Galmed Pharmaceuticals Ltd
CEO-
Employees5
Founded2000
Headquarters-
SectorBiotechnology
Websitegalmedpharma.com
Analyst ratings
Based on 1 analyst giving stock ratings to GLMD in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for GLMD in the last 3 months
Highest
Current $0.54
(-100.00%)
Average
(-100.00%)
Lowest
(-100.00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Naz Rahman
Maxim Group
Hold
Maintained
-
-
06/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.06M
1.09M
2.10M
1.36M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.05M
1.01M
946.00K
684.00K
Operating expense
2.11M
2.10M
3.04M
2.04M
Total operating expenses
2.11M
2.10M
3.04M
2.04M
Operating income
-2.11M
-2.10M
-3.04M
-2.04M
Other non operating income
-
-
-16.00K
134.00K
EBT including unusual items
-2.50M
-1.89M
-4.82M
-1.91M
EBT excluding unusual items
-1.97M
-1.89M
-2.79M
-1.91M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.50M
-1.89M
-4.82M
-1.91M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
140.00K
203.00K
420.00K
-
Interest expense
-
-
-79.00K
-
Net interest expenses
140.00K
203.00K
341.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.09M
-2.07M
-3.02M
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer